Sherbrooke Park Advisers LLC Merck & Co., Inc. Transaction History
Sherbrooke Park Advisers LLC
- $313 Billion
- Q4 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 8,058 shares of MRK stock, worth $750,280. This represents 0.26% of its overall portfolio holdings.
Number of Shares
8,058
Previous 12,952
37.79%
Holding current value
$750,280
Previous $1.47 Billion
45.5%
% of portfolio
0.26%
Previous 0.34%
Shares
5 transactions
Others Institutions Holding MRK
# of Institutions
3,972Shares Held
1.94BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$23.4 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.3 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$11.3 Billion0.49% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.7 Billion0.48% of portfolio
-
Morgan Stanley New York, NY44.2MShares$4.11 Billion0.32% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $236B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...